» Articles » PMID: 36579507

Clinical and Virological Characteristics and Prognostic Factors in Viral Necrotizing Retinitis

Overview
Journal J Pers Med
Date 2022 Dec 29
PMID 36579507
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Describe the clinical and virological characteristics of viral necrotizing retinitis (VNR) and assess its prognostic factors. Methods: Retrospective study (Pitié Salpêtrière Hospital, Paris) of consecutive VNR patients diagnosed and monitored by qPCR on aqueous humor between 2015 and 2019. All patients received induction therapy with intravenous +/− intravitreal injections (IVI) of antivirals. Results: Forty-one eyes of 37 patients with a mean age of 56 years were included. Involved viruses were VZV (44%), CMV (37%) and HSV2 (19%). Acute retinal necrosis represented 51%, progressive outer retinal necrosis 12% and CMV retinitis 37% of eyes. Forty-six percent of patients were immunocompromised. Median BCVA was 0.7 LogMAR at baseline and 0.8 LogMAR after an average of 14.1 months. VNR bilateralized in 27% of cases after 32 months. Retinal detachment (RD) occurred in 27% of cases after a mean duration of 98 days. Factors associated with a “poor BCVA” at 1 month were: advanced age, low baseline BCVA, high vitritis grade and viral load (VL) at baseline and the “slow responder” status (i.e., VL decrease <50% after 2 weeks of treatment). Factors associated with RD were: advanced age, immunocompetence, low baseline BCVA, high vitritis grade at baseline and use of ≤5 IVIs. Conclusions: Clinical factors including advanced age, immunocompetence, low BCVA and high vitritis grade at baseline were associated with a poor prognosis. New virological factors were predictive of a poor outcome: high baseline VL and the “slow responder” status. Sequential intraocular fluid sampling might help prognosticate the outcomes of VNR.

Citing Articles

Atypical Peripheral Retinal Necrosis Without Ocular Inflammation and Retinal Whitening in a Patient With Acute Myelogenous Leukemia: A Case Report.

Nakagawa Y, Tan X, Yoshida H, Suzuki T, Suzuki Y Cureus. 2024; 16(2):e54169.

PMID: 38496190 PMC: 10941302. DOI: 10.7759/cureus.54169.

References
1.
Roy R, Pal B, Mathur G, Rao C, Das D, Biswas J . Acute retinal necrosis: clinical features, management and outcomes--a 10 year consecutive case series. Ocul Immunol Inflamm. 2014; 22(3):170-4. DOI: 10.3109/09273948.2013.819928. View

2.
Kanoff J, Sobrin L . New diagnosis and treatment paradigms in acute retinal necrosis. Int Ophthalmol Clin. 2011; 51(4):25-31. DOI: 10.1097/IIO.0b013e31822d6864. View

3.
Butler N, Moradi A, Salek S, Burkholder B, Leung T, Dunn J . Acute Retinal Necrosis: Presenting Characteristics and Clinical Outcomes in a Cohort of Polymerase Chain Reaction-Positive Patients. Am J Ophthalmol. 2017; 179:179-189. DOI: 10.1016/j.ajo.2017.05.006. View

4.
Usui Y, Goto H . Overview and diagnosis of acute retinal necrosis syndrome. Semin Ophthalmol. 2008; 23(4):275-83. DOI: 10.1080/08820530802111325. View

5.
Tran T, Rozenberg F, Cassoux N, RAO N, LeHoang P, Bodaghi B . Polymerase chain reaction analysis of aqueous humour samples in necrotising retinitis. Br J Ophthalmol. 2002; 87(1):79-83. PMC: 1771476. DOI: 10.1136/bjo.87.1.79. View